Ligand-Specific Targeting of Microspheres to Phagocytes by Surface Modification with Poly(L-Lysine)-Grafted Poly(Ethylene Glycol) Conjugate
暂无分享,去创建一个
Marcus Textor | Hans P. Merkle | János Vörös | M. Textor | G. Csucs | J. Vörös | H. Merkle | E. Walter | Elke Walter | Sofia Faraasen | Gábor Csúcs | Sofia Faraasen
[1] D. Absolom. [13] Opsonins and dysopsonins: An overview , 1986 .
[2] M A Tracy,et al. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. , 1999, Biomaterials.
[3] S. Davis,et al. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. , 1991, Biochemical and biophysical research communications.
[4] G. Danuser,et al. Surface modification of PLGA microspheres. , 2003, Journal of biomedical materials research. Part A.
[5] Hans P. Merkle,et al. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres : importance of polymer degradation and antigen release for immune response , 1996 .
[6] M. Lück,et al. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[7] Marcus Textor,et al. Poly(l-lysine)-g-poly(ethylene glycol) Layers on Metal Oxide Surfaces: Surface-Analytical Characterization and Resistance to Serum and Fibrinogen Adsorption , 2001 .
[8] Anderson,et al. Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.
[9] C. Cho,et al. Receptor-mediated delivery of all trans-retinoic acid to hepatocyte using poly(L-lactic acid) nanoparticles coated with galactose-carrying polystyrene. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[10] A. Poggi,et al. The selective engulfment of apoptotic bodies by dendritic cells is mediated by the αvβ3 integrin and requires intracellular and extracellular calcium , 1997 .
[11] A. Karydas,et al. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[12] J. Feijen,et al. Cellular Uptake of PEO Surface-Modified Nanoparticles: Evaluation of Nanoparticles Made of PLA: PEO Diblock and Triblock Copolymers , 2000, Journal of drug targeting.
[13] R. Müller,et al. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. , 1996, Journal of drug targeting.
[14] D. Absolom. Opsonins and dysopsonins: an overview. , 1986, Methods in enzymology.
[15] Douglas J. Goetz,et al. Ligand Coated Nanosphere Adhesion to E- and P-Selectin under Static and Flow Conditions , 2001, Annals of Biomedical Engineering.
[16] P. Ricciardi-Castagnoli,et al. Fcγ Receptor–mediated Induction of Dendritic Cell Maturation and Major Histocompatibility Complex Class I–restricted Antigen Presentation after Immune Complex Internalization , 1999, The Journal of experimental medicine.
[17] K. Matsumoto,et al. Marked hypotensive and blood flow-increasing effects of a new lipo-PGE(1) (lipo-AS013) due to vascular wall targeting. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[18] H. Merkle,et al. Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[19] D. A. Kharkevich,et al. Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles , 1995 .
[20] R. Weissleder,et al. An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: synthesis and cytotoxic properties. , 1996, Bioconjugate chemistry.
[21] B. Gander,et al. Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[22] H. Merkle,et al. Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[23] Douglas S Kwon,et al. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.
[24] H. Merkle,et al. Microparticle-mediated Transfection of Non-phagocytic Cells In Vitro , 2002, Journal of drug targeting.
[25] J. Kim,et al. Targeted antigen delivery to antigen–presenting cells including dendritic cells by engineered Fas-mediated apoptosis , 2000, Nature Biotechnology.
[26] Martyn C. Davies,et al. In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers , 1997 .
[27] T. Nagai,et al. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[28] J. Hubbell,et al. Poly(l-lysine)-g-Poly(ethylene glycol) Layers on Metal Oxide Surfaces: Attachment Mechanism and Effects of Polymer Architecture on Resistance to Protein Adsorption† , 2000 .
[29] Janos Vörös,et al. RGD-grafted poly-L-lysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion. , 2003, Biotechnology and bioengineering.
[30] W. Shen,et al. Methotrexate‐poly(lysine) as a selective agent for mutants of chinese hamster ovary cells defective in endocytosis , 1988, Journal of cellular physiology.
[31] A. Maruyama,et al. Receptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymers. , 2001, Biomaterials.
[32] R. Müller,et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.
[33] Q. Myrvik,et al. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production. , 1997, Journal of immunology.
[34] N. Phillips,et al. Influence of Surface Properties at Biodegradable Microsphere Surfaces: Effects on Plasma Protein Adsorption and Phagocytosis , 1998, Pharmaceutical Research.
[35] M C Davies,et al. Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro. , 1991, Biomaterials.
[36] R. Löbenberg,et al. Influence of the surfactant concentration on the body distribution of nanoparticles. , 1999, Journal of drug targeting.
[37] M. Khan,et al. Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[38] J. Koda,et al. Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC). , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[39] P. Romero,et al. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway , 2000, Nature Immunology.
[40] L. Illum,et al. Influence of block copolymers on the adsorption of plasma proteins to microspheres. , 1993, Biomaterials.
[41] H. Merkle,et al. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[42] C Danieli,et al. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.
[43] J. Hubbell,et al. Self-assembly and steric stabilization at heterogeneous, biological surfaces using adsorbing block copolymers. , 1998, Chemistry & biology.
[44] M. Shive,et al. Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .
[45] R. Gurny,et al. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. , 1995, Life sciences.
[46] R. Müller,et al. Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. , 1987, Biomaterials.
[47] Y. Kawashima,et al. Prolonged circulation time of doxorubicin-loaded liposomes coated with a modified polyvinyl alcohol after intravenous injection in rats. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[48] E. Rodriguez-Boulan,et al. Macrophage and Retinal Pigment Epithelium Phagocytosis , 1999, The Journal of experimental medicine.
[49] A. Klibanov,et al. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. , 1999, Advanced drug delivery reviews.
[50] A. Poggi,et al. The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium. , 1997, European journal of immunology.
[51] Michel Veillard,et al. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers , 1995 .
[52] M. Albert,et al. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.
[53] R Weissleder,et al. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. , 1993, Radiology.
[54] R. Müller,et al. The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles. , 2001, International journal of pharmaceutics.
[55] L. Nicod,et al. Human lung dendritic cells have an immature phenotype with efficient mannose receptors. , 1999, American journal of respiratory cell and molecular biology.
[56] Lisbeth Illum,et al. Modification of the Copolymers Poloxamer 407 and Poloxamine 908 can Affect the Physical and Biological Properties of Surface Modified Nanospheres , 1998, Pharmaceutical Research.